Revolution Medicines (NASDAQ: RVMD) trust plans 3,000-share Rule 144 sale
Rhea-AI Filing Summary
Revolution Medicines, Inc. (symbol RVMD) received a notice that The Jonathan Goldsmith Revocable Trust, with Mark A. Goldsmith signing as trustee, has filed to sell shares of the company under Rule 144. The trust plans to sell 3,000 shares of common stock that were originally acquired as Founders Shares on 11/25/2014. The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with a stated aggregate market value of about $635,205.00 tied to 214,336,418 shares referenced in the form.
The filing also reports that during the past three months, 10,020 shares of Revolution Medicines common stock were sold on 06/16/2026 for total proceeds of approximately $1,564,310.38. The notice is signed and dated, indicating an intention to rely on Rule 144’s resale provisions for these securities.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Form 144 regulatory
Revocable Trust financial
FAQ
What does the Form 144 filing disclose for Revolution Medicines (RVMD)?
What recent sales of RVMD stock are reported in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.